课题基金 / 基金详情

High resolution volumetric MRI for prostate cancer active surveillance

High resolution volumetric MRI for prostate cancer active surveillance
高分辨率体积 MRI 用于前列腺癌主动监测
批准号:
9919515
负责人:
HYUNG L KIM
金额:
$38.02万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-05-01 至 2022-04-30

项目摘要

项目成果

HYUNG L KIM的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY The vast majority of men diagnosed with prostate cancer do not die of their disease and can choose to delay or avoid surgical or radiation treatment by undergoing active surveillance. Unfortunately, men on active surveillance remain at risk for progression of prostate cancer and even death from prostate cancer. Therefore, men are carefully followed with transrectal prostate biopsies every 1-2 years. Unlike with tumors in other organs, there is no imaging modality that can be used to accurately detect and monitor prostate tumors. Furthermore, prostate biopsies are painful and associated with a significant risk of sepsis and hospitalization. Therefore, the personal and public health burden of life-long active surveillance is significant. We introduce a novel MRI sequence that improves image quality and resolution. Our preliminary data shows that in men on active surveillance, standard MRI detects only 61% of biopsy-proven prostate tumors. However, our novel HR- MRI detects nearly all (96%) biopsy-proven prostate tumors, which is iimpressive since men on active surveillance tend to have small, low grade tumors. Our HR-MRI used to generate our preliminary data had a 5-fold improvement in resolution; however, the resolution can be improved up to 25-fold at a cost of increased scan time. The first aim will be to further optimize our HR-MRI to improve resolution and image quality while minimizing the scan time. The optimized HR-MRI will be used to detect changes in tumor size or grade in men on active surveillance and consider the possibiity that tumor growth rate or other imaging characteristics predict the risk of disease progression. A more accurate MRI modality for localizing and monitoring prostate tumors will allow men on active surveillance to reduce the number of followup biopsies, identify tumors for biopsies that can be used for molecular characterization, and localize tumors for focal ablative therapies. The HR-MRI can be deployed on existing 1.5T and 3T MRI systems with a simple software installation and does not require new hardware.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer
  • 批准号:
    10802975
  • 项目类别:
  • 资助金额:
    $69.2万
  • 财政年份:
    2023
  • 负责人:
    HYUNG L KIM
  • 依托单位:
Qualifying Multi-Transcript Signatures for Active Surveillance of Prostate Cancer
  • 批准号:
    8762344
  • 项目类别:
  • 资助金额:
    $60.56万
  • 财政年份:
    2014
  • 负责人:
    HYUNG L KIM
  • 依托单位:
Qualifying Multi-Transcript Signatures for Active Surveillance of Prostate Cancer
  • 批准号:
    8920108
  • 项目类别:
  • 资助金额:
    $50.03万
  • 财政年份:
    2014
  • 负责人:
    HYUNG L KIM
  • 依托单位:
Qualifying Multi-Transcript Signatures for Active Surveillance of Prostate Cancer
  • 批准号:
    9307744
  • 项目类别:
  • 资助金额:
    $49.58万
  • 财政年份:
    2014
  • 负责人:
    HYUNG L KIM
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: